- Health Canada DPD: JAMP-LATANOPROST/TIMOLOL (JAMP PHARMA CORPORATION, DIN 02453770) · product monograph (PDF)
- Health Canada DPD: LATANOPROST / TIMOLOL (JAMP PHARMA CORPORATION, DIN 02553848) · product monograph (PDF)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: XALATAN is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. US FDA label
Use: INDICATIONS AND USAGE TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic solution: 50 mcg/5 mg
- Per ml: 50 mcg/5 mg
Registered products in the Philippines
6 products registered with the Food and Drug Administration (FDA) Philippines list Latanoprost + Timolol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products6
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AstimolLatanoprost + Timolol (as maleate) | 50 mcg / 5 mg per mL Ophthalmic SolutionIn 5 mL White LDPE Bottle x 2.5 mL with dropper-undercap cap (Box of 1's) | Rx | Rafarm SAGreece | Aspen Philippines Inc.Trader: NTC SRL | DR-XY45555 | Dec 8, 2031 | |
Latochek-TLatanoprost + Timolol (as maleate) | 50 mcg/5 mg per mL Ophthalmic Solution (Eye Drops)2.5 mL in 5 mL-capacity LDPE bottle with white HDPE cap (Box of 1’s) | Rx | Indoco Remedies LimitedIndia | Ambica International Corporation | DRP-8943 | Jul 6, 2030 | |
Ocupres PlusLatanoprost Timolol (as maleate) | 50 mcg/ 5mg per mL Ophthalmic Solution5 mL-Net Capcity White LDPE bottle with White LDPE dropper-undercap and White LDPE cap x 2.5 mL (Box of 1's) | Rx | Rafarm SAGreece | Unilab, Inc. | DRP-16809 | Jul 15, 2030 | |
XalacomLatanoprost + Timolol (as maleate) | 50 mcg/ 5 mg per mL Ophthalmic Solution2. 5 mL LDPE Plastic Bottle (Box of 1's) | Rx | Pfizer Manufacturing Belgium NVBelgium | Importer: Viatris, Inc. | DRP-3382 | Dec 5, 2029 | |
XalanolLatanoprost + Timolol (as maleate) | 50 mcg/5 mg per ml (0.005% / 0.5%) | Rx | Beximco Pharmaceuticals Ltd | — | DR-XY45748 | Jan 16, 2027 | |
XalanolLatanoprost + Timolol (as maleate) | 50 mcg/5 mg per ml (0.005%/ 0.5%) Ophthalmic Solution (Eye Drops)LDPE Plastic Container and Dropper with HDPE Cap x 2.5 mL (Box of 1’s) | Rx | Beximco Pharmaceuticals Ltd.Bangladesh | I-Senz Medical IncImporter: Ambica International Corporation | DRP-11166 | Jan 16, 2032 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Latanoporst + Timolol maleate |
| PNF listing | Opthalmic Solution: 50 mcg + 5 mg/mL, 5 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .